Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications
View Patent ↗It is an object of the instant invention to provide a method for the rapid evaluation of novel sugar modifications to be used in siRNA synthesis including the rapid evaluation of chemical modification patterns within the siRNA to effectuate increased stability and ultimately increased efficacy of a siRNA therapeutic. It is a further object of the instant invention to provide novel nucleosides useful for siRNA therapy.
1. A method for evaluating 1 or more chemical modifications in an siRNA, said method comprising:
a) providing a siRNA oligomer with 1 or more sugar un-modified universal base containing nucleosides;
b) measuring position-specific data to create a baseline data;
c) providing a siRNA oligomer with 1 or more sugar modified universal base containing nucleosides at the same position of the un-modified universal base(s) of step a);
d) measuring position-specific data,
wherein a change in the position-specific data from step d) relative to the baseline data is indicative of siRNA function.
2. The method of claim 1 , wherein the position-specific data is position-specific knockdown data.
3. The method of claim 1 , wherein the evaluation of the position-specific data comprises detecting target mRNA degradation.
4. The method of claim 3 , wherein the target mRNA degradation is detected by quantitative PCR.
5. The method of claim 1 , wherein the universal base is a hydrogen atom, inosine, modified adenine, modified guanine, modified uracil, modified cytosine, thymine, modified thymine, 2-aminoadenosine, 5-methylcytosine, 2,6-diaminopurine, naphthyl, 3-nitropyrrole, imidazole-4-carboxamide, 5-nitroindole, nebularine, pyridone, or pyridinone.
6. The method of claim 1 , wherein the universal base is inosine.
7. The method of claim 1 , wherein the universal base is anhydroribitol.
8. The method of claim 1 , wherein the sugar-modified universal base comprises a 2′-O-ribose modification.
9. The method of claim 8 , wherein the 2′-O-ribose modification is a 2′-O-benzyl, 2′-O-methylene-(β-naphthyl), 2′-O-(2-difluoromethoxybenzyl), or 2′-O-methylene-(4-pyridyl) modification.
10. The method of claim 1 , wherein the siRNA is a double stranded siRNA.
11. The method of claim 10 , wherein the siRNA comprises overhangs.
12. The method of claim 1 , wherein measuring position-specific data in step b) comprises contacting the siRNA oligomer of step a) with a target mRNA.
13. The method of claim 12 , which further comprises detecting target mRNA degradation.
14. The method of claim 1 , wherein measuring position-specific data in step d) comprises contacting the siRNA oligomer of step c) with a target mRNA.
15. The method of claim 14 , which further comprises detecting target mRNA degradation.
16. The method of claim 1 , wherein measuring position-specific data in step b) comprises contacting a cell with the siRNA oligomer of step a).
17. The method of claim 1 , wherein measuring position-specific data in step d) comprises contacting a cell with the siRNA oligomer of step c).
18. The method of claim 1 , which comprises comparing the position specific data from step d) to the baseline data.